SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Cummings T) "

Sökning: WFRF:(Cummings T)

  • Resultat 321-325 av 325
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
321.
  • Molinuevo, J. L., et al. (författare)
  • Current state of Alzheimer's fluid biomarkers
  • 2018
  • Ingår i: Acta Neuropathologica. - : Springer Science and Business Media LLC. - 0001-6322 .- 1432-0533. ; 136:6, s. 821-853
  • Forskningsöversikt (refereegranskat)abstract
    • Alzheimer's disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiology. The number of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clinical trials. Fluid biomarkers measured in cerebrospinal fluid (CSF) or blood hold promise for enabling more effective drug development and establishing a more personalized medicine approach for AD diagnosis and treatment. Biomarkers used in drug development programmes should be qualified for a specific context of use (COU). These COUs include, but are not limited to, subject/patient selection, assessment of disease state and/or prognosis, assessment of mechanism of action, dose optimization, drug response monitoring, efficacy maximization, and toxicity/adverse reactions identification and minimization. The core AD CSF biomarkers A42, t-tau, and p-tau are recognized by research guidelines for their diagnostic utility and are being considered for qualification for subject selection in clinical trials. However, there is a need to better understand their potential for other COUs, as well as identify additional fluid biomarkers reflecting other aspects of AD pathophysiology. Several novel fluid biomarkers have been proposed, but their role in AD pathology and their use as AD biomarkers have yet to be validated. In this review, we summarize some of the pathological mechanisms implicated in the sporadic AD and highlight the data for several established and novel fluid biomarkers (including BACE1, TREM2, YKL-40, IP-10, neurogranin, SNAP-25, synaptotagmin, -synuclein, TDP-43, ferritin, VILIP-1, and NF-L) associated with each mechanism. We discuss the potential COUs for each biomarker.
  •  
322.
  • Pajunoja, Aki, et al. (författare)
  • Adsorptive uptake of water by semisolid secondary organic aerosols
  • 2015
  • Ingår i: Geophysical Research Letters. - 0094-8276 .- 1944-8007. ; 42:8, s. 3063-3068
  • Tidskriftsartikel (refereegranskat)abstract
    • Aerosol climate effects are intimately tied to interactions with water. Here we combine hygroscopicity measurements with direct observations about the phase of secondary organic aerosol (SOA) particles to show that water uptake by slightly oxygenated SOA is an adsorption-dominated process under subsaturated conditions, where low solubility inhibits water uptake until the humidity is high enough for dissolution to occur. This reconciles reported discrepancies in previous hygroscopicity closure studies. We demonstrate that the difference in SOA hygroscopic behavior in subsaturated and supersaturated conditions can lead to an effect up to about 30% in the direct aerosol forcinghighlighting the need to implement correct descriptions of these processes in atmospheric models. Obtaining closure across the water saturation point is therefore a critical issue for accurate climate modeling.
  •  
323.
  • Van Deerlin, Vivian M, et al. (författare)
  • Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
  • 2010
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 42:3, s. 234-239
  • Tidskriftsartikel (refereegranskat)abstract
    • Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. The predominant neuropathology is FTLD with TAR DNA-binding protein (TDP-43) inclusions (FTLD-TDP). FTLD-TDP is frequently familial, resulting from mutations in GRN (which encodes progranulin). We assembled an international collaboration to identify susceptibility loci for FTLD-TDP through a genome-wide association study of 515 individuals with FTLD-TDP. We found that FTLD-TDP associates with multiple SNPs mapping to a single linkage disequilibrium block on 7p21 that contains TMEM106B. Three SNPs retained genome-wide significance following Bonferroni correction (top SNP rs1990622, P = 1.08 x 10(-11); odds ratio, minor allele (C) 0.61, 95% CI 0.53-0.71). The association replicated in 89 FTLD-TDP cases (rs1990622; P = 2 x 10(-4)). TMEM106B variants may confer risk of FTLD-TDP by increasing TMEM106B expression. TMEM106B variants also contribute to genetic risk for FTLD-TDP in individuals with mutations in GRN. Our data implicate variants in TMEM106B as a strong risk factor for FTLD-TDP, suggesting an underlying pathogenic mechanism.
  •  
324.
  • Whiffin, N, et al. (författare)
  • The effect of LRRK2 loss-of-function variants in humans
  • 2020
  • Ingår i: Nature medicine. - : Springer Science and Business Media LLC. - 1546-170X .- 1078-8956. ; 26:6, s. 869-877
  • Tidskriftsartikel (refereegranskat)abstract
    • Human genetic variants predicted to cause loss-of-function of protein-coding genes (pLoF variants) provide natural in vivo models of human gene inactivation and can be valuable indicators of gene function and the potential toxicity of therapeutic inhibitors targeting these genes1,2. Gain-of-kinase-function variants in LRRK2 are known to significantly increase the risk of Parkinson’s disease3,4, suggesting that inhibition of LRRK2 kinase activity is a promising therapeutic strategy. While preclinical studies in model organisms have raised some on-target toxicity concerns5–8, the biological consequences of LRRK2 inhibition have not been well characterized in humans. Here, we systematically analyze pLoF variants in LRRK2 observed across 141,456 individuals sequenced in the Genome Aggregation Database (gnomAD)9, 49,960 exome-sequenced individuals from the UK Biobank and over 4 million participants in the 23andMe genotyped dataset. After stringent variant curation, we identify 1,455 individuals with high-confidence pLoF variants in LRRK2. Experimental validation of three variants, combined with previous work10, confirmed reduced protein levels in 82.5% of our cohort. We show that heterozygous pLoF variants in LRRK2 reduce LRRK2 protein levels but that these are not strongly associated with any specific phenotype or disease state. Our results demonstrate the value of large-scale genomic databases and phenotyping of human loss-of-function carriers for target validation in drug discovery.
  •  
325.
  • Wood, Jack, 1997, et al. (författare)
  • Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology
  • 2022
  • Ingår i: Cell Reports. - : Elsevier BV. - 2211-1247. ; 41:8
  • Tidskriftsartikel (refereegranskat)abstract
    • Using spatial cell-type-enriched transcriptomics, we compare plaque-induced gene (PIG) expression in mi-croglia-touching plaques, neighboring plaques, and far from plaques in an aged Alzheimer's mouse model with late plaque development. In 18-month-old APPNL-F/NL-F knockin mice, with and without the Alzheimer's disease risk mutation Trem2R47H/R47H, we report that expression of 38/55 PIGs have plaque-induced micro-glial upregulation, with a subset only upregulating in microglia directly contacting plaques. For seven PIGs, including Trem2, this upregulation is prevented in APPNL-F/NL-FTrem2R47H/R47H mice. These TREM2-depen-dent genes are all involved in phagocytic and degradative processes that we show correspond to a decrease in phagocytic markers and an increase in the density of small plaques in Trem2-mutated mice. Furthermore, despite the R47H mutation preventing increased Trem2 gene expression, TREM2 protein levels and micro-glial density are still marginally increased on plaques. Hence, both microglial contact with plaques and func-tioning TREM2 are necessary for microglia to respond appropriately to amyloid pathology.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 321-325 av 325
Typ av publikation
tidskriftsartikel (316)
forskningsöversikt (5)
konferensbidrag (2)
Typ av innehåll
refereegranskat (320)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Cummings, J. (260)
Chen, C. (255)
Blumenschein, U. (254)
Abbott, B. (253)
Amram, N. (253)
Andeen, T. (253)
visa fler...
Andreazza, A. (253)
Annovi, A. (253)
Arai, Y. (253)
Artoni, G. (253)
Avolio, G. (253)
Backes, M. (253)
Beck, H. P. (253)
Bell, W. H. (253)
Bellagamba, L. (253)
Bellomo, M. (253)
Benhammou, Y. (253)
Bianco, M. (253)
Bindi, M. (253)
Blair, R. E. (253)
Boisvert, V. (253)
Borissov, G. (253)
Brock, R. (253)
Burdin, S. (253)
Burke, S. (253)
Busato, E. (253)
Buttinger, W. (253)
Campanelli, M. (253)
Caron, S. (253)
Casadei, D. (253)
Casado, M. P. (253)
Cerri, A. (253)
Cerrito, L. (253)
Chakraborty, D. (253)
Cheatham, S. (253)
Chen, X. (253)
Cheu, E. (253)
Chevalier, L. (253)
Coccaro, A. (253)
Cooke, M. (253)
Cooper, B. D. (253)
Cranmer, K. (253)
Dam, M. (253)
Dao, V. (253)
De Cecco, S. (253)
De Santo, A. (253)
Demers, S. (253)
Ehrenfeld, W. (253)
Ellis, N. (253)
Elmsheuser, J. (253)
visa färre...
Lärosäte
Lunds universitet (276)
Uppsala universitet (244)
Stockholms universitet (238)
Kungliga Tekniska Högskolan (233)
Göteborgs universitet (31)
Karolinska Institutet (26)
visa fler...
Umeå universitet (6)
Chalmers tekniska högskola (3)
Örebro universitet (1)
Mittuniversitetet (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (324)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (266)
Medicin och hälsovetenskap (43)
Teknik (1)
Lantbruksvetenskap (1)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy